nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-BC0EAFF5·Framework v5.0·Pipeline v0.4·Evaluated 11 Jun 2026·OECD: 3.1 Basic medicine·Subfield: Cell Biology·Basis: Full text·Type: Laboratory experiment

The BICD2 dynein cargo adaptor binds to the HPV16 L2 capsid protein and promotes HPV infection.

Speckhart et al.Speckhart, Choi, DiMaio et al.·2024·PLoS pathogens·10.1371/journal.ppat.1012289 ↗

In brief

A rigorously triangulated study identifying BICD2 as the dynein adaptor that recruits HPV to the motor, constrained by binding-site overlap that prevents clean functional separation.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Abstract

During entry, human papillomavirus (HPV) traffics from the endosome to the trans Golgi network (TGN) and Golgi and then the nucleus to cause infection. Although dynein is thought to play a role in HPV infection, how this host motor recruits the virus to support infection and which entry step(s) requires dynein are unclear. Here we show that the dynein cargo adaptor BICD2 binds to the HPV L2 capsid protein during entry, recruiting HPV to dynein for transport of the virus along the endosome-TGN/Golgi axis to promote infection. In the absence of BICD2 function, HPV accumulates in the endosome and TGN and infection is inhibited. Cell-based and in vitro binding studies identified a short segment near the C-terminus of L2 that can directly interact with BICD2. Our results reveal the molecular basis by which the dynein motor captures HPV to promote infection and identify this virus as a novel cargo of the BICD2 dynein adaptor.

Strengths · Limitations

Strengths

#methodological rigour

Orthogonal assays converge on one mechanism

The BICD2-L2 interaction is supported by immunoprecipitation-mass spectrometry, co-IP time courses, proximity ligation in intact cells, direct binding of purified proteins, and knockdown-rescue, providing strong triangulation across independent methods.

↳ Results, Figs 1-4

#methodological rigour

Rigorous specificity controls including dynein-defective mutant

A dynein-binding-defective A/V BICD2 mutant fails to rescue infection while retaining cargo binding, and siRNA-resistant rescue constructs confirm on-target specificity, isolating the dynein-coupling function from off-target effects.

↳ Results, Fig 4A-C

#contribution

Mechanism generalizes across oncogenic HPV types

BICD2 is required for HPV5, HPV16, and HPV18 infection, and the L2 C-terminal binding region is conserved across these types, indicating the recruitment mechanism is broadly applicable.

↳ Results, Fig 3C-D and S3A Fig

Limitations

#methodological rigour

Mechanistic inference relies on indirect evidence

Key claims about motor-driven transport rest on co-IP and proximity ligation signals together with depletion phenotypes rather than direct visualization of dynein-driven movement of the virus.

↳ Results, Figs 1, 4, 5

#contribution

Binding site overlaps other L2 functional motifs

The BICD2 binding segment overlaps the retromer binding site and the cell-penetrating peptide, and alanine substitutions disrupt all functions together, so the trafficking defect cannot be cleanly attributed to loss of BICD2 binding alone.

↳ Results, Fig 2; Discussion, paragraph 5

#application pathway

All functional work in transformed cell lines

Experiments use HeLa and HaCaT cells and pseudovirus systems, with no validation in primary keratinocytes, the natural HPV target tissue, or in vivo, limiting physiological generalizability.

↳ Materials and Methods; Results

Does this match your read? Add your assessment ↓

Nabu Commentary

The scores reflect a coherent, well-controlled mechanistic study whose central advance is identifying BICD2 as the dynein adaptor for HPV and localizing the interaction to a defined L2 segment. Evaluation converged on the strength of the multi-assay triangulation and the dynein-binding-defective mutant control, which together make the BICD2-L2-dynein link convincing. The principal point of divergence concerned execution: the binding site mapped in Fig 2 overlaps the retromer site and cell-penetrating peptide, and because no separation-of-function L2 mutant exists, the trafficking defect cannot be attributed solely to BICD2 binding, which bounds both Methodological Rigour and Contribution below the top band. Impact potential is decoupled from quality and sits in the recognized-problem-area range because the findings are pre-translational, conducted in transformed cell lines without a therapeutic prototype.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
4.0±0.1

Contribution
4.1

The paper identifies BICD2 as the cargo adaptor bridging HPV L2 to dynein and maps the interaction to a 20-amino-acid L2 C-terminal segment, filling a defined mechanistic gap in HPV entry and adding a novel cargo to the BICD2 field. The contribution is bounded by the inability to generate separation-of-function L2 mutants that ablate BICD2 binding without disrupting other L2 functions.

Introduction, paragraphs 3-4; Results (Figs 1-2); Discussion, paragraph 5

we cannot rigorously test the model that BICD2 binding to L2 is required for proper trafficking

Methodological Rigour
3.8

Execution is strong through orthogonal assays (IP-MS, co-IP time courses, PLA, purified-protein binding, KD-rescue) and well-chosen controls including the dynein-binding-defective A/V BICD2 mutant. The score is bounded because central inferences rest on co-IP/PLA proximity and depletion rather than direct transport measurement, and the mapped binding site overlaps the retromer site and CPP, preventing clean functional separation.

Results (Figs 1-5); Fig 2 (binding-site overlap); Fig 4A-C (control); Materials and Methods

Substitution of either the retromer binding site or the CPP with alanines... severely impaired BICD2 binding

Reporting
4.2

The argument proceeds logically from interaction discovery to direct binding to functional KD-rescue and trafficking consequences, with a summarizing model figure. Minor imprecision arises where the discussion moves from association to 'recruits' and 'coupling' beyond what proximity and depletion strictly demonstrate.

Abstract; Results; Discussion; Fig 5E

recruiting HPV to dynein for transport of the virus along the endosome-TGN/Golgi axis

Positioning
4.0

The paper engages substantively with prior HPV entry literature (retromer, Rab, COPI, dynein light chain) and BICD2 biology, positioning itself as filling a specific mechanistic gap and honestly noting unresolved questions such as the role of BICDR1. Comparison to the yeast two-hybrid L2-dynein study and to RanBP10/KPNA2 contextualizes the finding.

Introduction; Discussion, paragraphs 6-8

different dynein adaptors may act at different stages during HPV entry

Lower confidence on Methodological Rigour — domain match limited.

Reliability

Caveats4 of 4 checks


Internal CoherenceClean

The paper is internally consistent across abstract, results, and discussion, with converging evidence (IP-MS, co-IP time courses, PLA, in vitro binding, KD-rescue) and no numerical contradictions or methods-results mismatches. Mechanistic language such as 'recruits' and 'coupling' is somewhat strong relative to proximity and depletion data, but claims remain directionally aligned with the evidence and the authors explicitly caveat the absence of separation-of-function mutants.

Research ConductNoted

No image integrity, COI, or protocol-registration red flags were identified. Ethics approval is not stated (acceptable for established cell lines but undeclared) and no data or code availability statement is provided.

Flags: 0 declared / 5 total

Reference IntegrityClean

All 52 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Cancer and neoplasms · Cervical cancer
Type of advanceEmpirical
Route to useNot stated
AdvanceAdvances
BeneficiariesLarge
CitationsFWCI 3.2
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The mechanism is pinned down under controlled cell culture conditions using pseudovirus infection, co-IP, PLA, and in vitro purified protein binding assays.

The paper states no real-world use of its own findings; it only says understanding HPV entry may reveal therapeutic strategies and calls for further analysis providing new insights.

Pathway

Researchers studying HPV entry could use the BICD2-L2 interaction as a target for developing antiviral therapeutics against established HPV infections.

Barrier

The findings come from cell culture pseudovirus systems, BICD2 is an essential host protein with normal cellular functions, and the authors note they cannot rigorously test the model due to overlapping L2 motifs.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. The ALS- and FTD-associated proteins annexin A11 and CHMP2B act sequentially in plasma membrane repair

    Heffner, Starling, Straker, et al. · 2026 · Basic medicine

    Primary claim

    annexin proteins are recruited immediately and form a plug at the damage site, restricting membrane permeability

    Supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats
  2. The fate of human SUSD2+ endometrial mesenchymal stem cells during decidualization

    Tina Gorsek Sparovec, Udo R Markert, Philipp Reif, et al. · 2022 · Basic medicine

    Primary claim

    Our results suggest that SUSD2+ eMSC undergo decidualization in vitro, while maintaining MSC plasma membrane phenotype.

    Tentative
    Evidence Score
    2.5±0.1
    Reliability
    Caveats
  3. Different regulation of IRE1α and eIF2α pathways by oxygen and insulin in ACH-3P trophoblast model

    Veronika Tandl, Denise Hoch, Julia Bandres-Meriz, et al. · 2021 · Basic medicine

    Primary claim

    Overall, our results suggest that IRE1α and eIF2α UPR-pathways are differentially regulated by oxygen and insulin [in ACH-3P trophoblast cells] in early pregnancy.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats

How the rubric works →